AGREEMENT AND PLAN OF MERGER among IDENIX PHARMACEUTICALS, INC., MERCK & CO., INC. and IMPERIAL BLUE CORPORATION Dated as of June 8, 2014Merger Agreement • June 9th, 2014 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER (hereinafter called this “Agreement”), dated as of June 8, 2014, by and among Idenix Pharmaceuticals, Inc., a Delaware corporation (the “Company”), Merck & Co., Inc., a New Jersey corporation (“Parent”), and Imperial Blue Corporation, a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub,” with the Company and Merger Sub sometimes being hereinafter collectively referred to as the “Constituent Corporations”).
SUPPORT AGREEMENTSupport Agreement • June 9th, 2014 • Idenix Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This SUPPORT AGREEMENT (this “Agreement”), dated as of June 8, 2014, is entered into by and among Merck & Co., Inc., a New Jersey corporation (“Parent”), Imperial Blue Corporation, a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), and The Baupost Group, L.L.C., a Massachusetts limited liability corporation (the “Stockholder”). All terms used but not otherwise defined in this Agreement shall have the respective meanings ascribed to such terms in the Merger Agreement (as defined below).
